Skip to main content
Knight Therapeutics Inc. (TSX:GUD)
Canada flag Canada · Delayed Price · Currency is CAD
7.38
-0.15 (-1.99%)
Apr 28, 2026, 4:00 PM EST

Knight Therapeutics Revenue

In the year 2025, Knight Therapeutics had annual revenue of 450.09M CAD with 21.22% growth. Knight Therapeutics had revenue of 133.11M in the quarter ending December 31, 2025, with 37.42% growth.

Revenue
450.09M
Revenue Growth
+21.22%
P/S Ratio
1.61
Revenue / Employee
542.27K
Employees
830
Market Cap
725.10M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025450.09M78.78M21.22%
Dec 31, 2024371.30M43.11M13.13%
Dec 31, 2023328.20M34.64M11.80%
Dec 31, 2022293.56M50.09M20.57%
Dec 31, 2021243.48M43.96M22.03%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Verano Holdings 1.13B
Canopy Growth 278.39M
Cresco Labs 899.24M
DRI Healthcare Trust 263.00M
Cipher Pharmaceuticals 69.17M
Cronos Group 200.99M
TerrAscend 357.26M
Aurora Cannabis 373.12M
Revenue Rankings

Knight Therapeutics News

More News